Targeting metabolic pathways to counter cancer immunotherapy resistance
Trends in Immunology · 2024-07 · 45 (7) · 486-494
DOI: 10.1016/j.it.2024.05.006 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Immunology, 2024-07. Verfasst von Yuki Agarwala und 4 weiteren Autor:innen. Beteiligte Einrichtung: Vaccine and Immunotherapy Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; Imperial College School of Medicine, Imper…. Hauptthemen laut MEDLINE: Neoplasms, Immunotherapy, Tumor Microenvironment, Metabolic Networks and Pathways. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 62 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Vaccine and Immunotherapy Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; Imperial College School of Medicine, Imperial College London, London SW7 2AZ, UK.
- Vaccine and Immunotherapy Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
- Vaccine and Immunotherapy Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: yhailu@mgh.harvard.edu.
Zitieren
APA
Agarwala, Y., Brauns, T. A., Sluder, A. E., Poznansky, M. C., & Gemechu, Y. (2024). Targeting metabolic pathways to counter cancer immunotherapy resistance. Trends in Immunology, 45(7), 486-494. https://doi.org/10.1016/j.it.2024.05.006
Vancouver
Agarwala Y, Brauns TA, Sluder AE, Poznansky MC, Gemechu Y. Targeting metabolic pathways to counter cancer immunotherapy resistance. Trends in Immunology. 2024;45(7):486-494. doi:10.1016/j.it.2024.05.006
BibTeX
@article{Agarwala2024,
author = {Agarwala, Yuki and Brauns, Timothy A and Sluder, Ann E and Poznansky, Mark C and Gemechu, Yohannes},
title = {Targeting metabolic pathways to counter cancer immunotherapy resistance},
journal = {Trends in Immunology},
year = {2024},
volume = {45},
number = {7},
pages = {486--494},
doi = {10.1016/j.it.2024.05.006}
}
EUVIMED